From: Clinical outcomes and risk factor of immune checkpoint inhibitors-related pneumonitis in non-small cell lung cancer patients with chronic obstructive pulmonary disease
Total
N = 61
Non-CIP (%)
n = 50
CIP (%)
n = 11
P
GOLD
0.796
1
20
16 (80.0)
4 (20.0)
2
22
19 (86.4)
3 (13.6)
3
19
15 (78.9)
4 (21.1)
4
0
0 (0)